The Executive Director of Statistical Programming provides strategic and operational leadership for statistical programming across clinical development programs. They oversee external vendors, establish programming standards, and partner with cross-functional teams to ensure high-quality regulatory submissions.
The Senior Director of Clinical Quality Assurance provides strategic leadership and oversight for global clinical trials to ensure compliance with GCP and regulatory requirements. They are responsible for managing clinical quality systems, leading inspection readiness activities, and overseeing risk-based audits and CAPA processes.
The Director, Corporate Counsel will lead the drafting, review, and negotiation of a wide range of clinical and commercial agreements to support drug development and manufacturing. They will serve as a key legal advisor to internal stakeholders, providing strategic counsel on risk management, compliance, and intellectual property matters.
The Vice President of Clinical Development will provide strategic and operational leadership for global ophthalmic genetic medicine programs, serving as the primary medical monitor for clinical trials. They are responsible for overseeing clinical study design, regulatory document preparation, and cross-functional collaboration with internal and external partners.
The Executive Medical Director will lead the design, execution, and analysis of clinical trials in the ophthalmology therapeutic area, specifically for Phase 1 retina clinical trials. Responsibilities include ensuring subject safety, data integrity, and leading cross-functional study teams.
